Comany: Precision Therapeutics
Based: Pittsburgh, PA
Investors: Adams Capital Management, Quaker BioVentures, Birchmere Ventures, Longitude Capital, TVM Capital, Draper Triangle Ventures
Scoop: Diagnostic company Precision Therapeutics booked up $43 million in a sixth round of funding. The money is being used to expand the development and commercialization of ChemoFx, a lab test that predicts how patient's cancer cells will respond to different chemotherapy agents prior to initiating the treatment.